Skip to main content

Table 8 Reported and observed available essential medicine for hypertension and diabetes

From: Managing non-communicable diseases at health district level in Cambodia: a systems analysis and suggestions for improvement

Medicine

Health centre

District hospital

PH

CDC

PEN

 

Interviewa

Assessedb

Interview

Assessed

   
 

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

Hypertension

Hydrochlorothiazide

5 (33)

12 (86)

3 (100)

1 (33)

0

1 (50)

2 (100)

Amlodipine

1 (7)

1 (7)

2 (67)

2 (67)

1 (33)

2 (100)

2 (100)

Atenolol

1 (7)

2 (14)

3 (100)

3 (100)

2 (67)

2 (100)

2 (100)

Captopril

NEDL

0

2 (67)

1 (33)

1 (50)

2 (100)

Enalapril

NEDL

1 (33)

3 (100)

1 (33)

2 (100)

2 (100)

Losartan

NEDL

0

0

0

0

1 (50)

Nifedipine

NEDL

1 (33)

2 (67)

0

0

0

Diabetes

Metformine

NEDL

1 (33)

2 (67)

2 (67)

2 (100)

2 (100)

Glibenclamide

NEDL

1 (33)

2 (67)

1 (33)

1 (50)

2 (100)

Insuline NPH

NEDL

0

1 (33)

1 (33)

2 (100)

2 (100)

  1. CDC chronic disease clinic, PEN peer education network, PH provincial hospital, NEDL not on essential drug list; a15 facilities; b14 facilities